Literature DB >> 9843158

Effect of benzodiazepines and neurosteroids on ammonia-induced swelling in cultured astrocytes.

A S Bender1, M D Norenberg.   

Abstract

Astroglial swelling occurs in acute hyperammonemic states, including acute hepatic encephalopathy. In these conditions, the peripheral-type benzodiazepine receptor (PBR), a receptor associated with neurosteroidogenesis, is up-regulated. This study examined the potential involvement of PBRs and neurosteroids in ammonia-induced astrocyte swelling in culture. At low micromolar concentrations, the PBR antagonist PK 11195, atrial natriuretic peptide, and protoporhyrin IX, which are known to interact with the PBR, attenuated (16-100%) the effects of ammonia, whereas the PBR agonists Ro5-4864, diazepam binding inhibitor (DBI51-70), and octadecaneuropeptide exacerbated (10-15%) the effects of ammonia. At micromolar concentrations, diazepam, which interacts with both the PBR and the central-type benzodiazepine receptor (CBR), increased swelling by 11%, whereas flumazenil, a CBR antagonist, had no effect. However, at 100 nM diazepam and flumazenil abrogated ammonia-induced swelling. The neurosteroids dehydroepiandrosterone sulfate, tetrahydroprogesterone, pregnenolone sulfate, and tetrahydrodeoxycorticosterone (THDOC), products of PBR stimulation, at micromolar concentrations significantly enhanced (70%) ammonia-induced swelling. However, at nanomolar concentrations, these neurosteroids, with exception of THDOC, blocked ammonia-induced swelling. We conclude that neurosteroids and agents that interact with the PBR influence ammonia-induced swelling. These agents may represent novel therapies for acute hyperammonemic syndromes and other conditions associated with brain edema and astrocyte swelling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843158     DOI: 10.1002/(SICI)1097-4547(19981201)54:5<673::AID-JNR12>3.0.CO;2-P

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  26 in total

Review 1.  Hepatic encephalopathy as a complication of liver disease.

Authors:  S vom Dahl; G Kircheis; D Häussinger
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Brain aquaporin-4 in experimental acute liver failure.

Authors:  Kakulavarapu V Rama Rao; Arumugam R Jayakumar; Xiaoying Tong; Kevin M Curtis; Michael D Norenberg
Journal:  J Neuropathol Exp Neurol       Date:  2010-09       Impact factor: 3.685

3.  Sulfonylurea receptor 1 contributes to the astrocyte swelling and brain edema in acute liver failure.

Authors:  A R Jayakumar; V Valdes; X Y Tong; N Shamaladevi; W Gonzalez; M D Norenberg
Journal:  Transl Stroke Res       Date:  2014-01-18       Impact factor: 6.829

Review 4.  Astroglial dysfunction in hepatic encephalopathy.

Authors:  M D Norenberg
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 5.  Aquaporin-4 in hepatic encephalopathy.

Authors:  K V Rama Rao; M D Norenberg
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 6.  RNA oxidation and zinc in hepatic encephalopathy and hyperammonemia.

Authors:  Freimut Schliess; Boris Görg; Dieter Häussinger
Journal:  Metab Brain Dis       Date:  2009-01-16       Impact factor: 3.584

7.  NFkappaB in the mechanism of ammonia-induced astrocyte swelling in culture.

Authors:  Anne P Sinke; Arumugam R Jayakumar; Kiran S Panickar; Mitsuaki Moriyama; Pichili V B Reddy; Michael D Norenberg
Journal:  J Neurochem       Date:  2008-07-04       Impact factor: 5.372

Review 8.  The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy.

Authors:  Samir Ahboucha; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 9.  The brain in acute liver failure. A tortuous path from hyperammonemia to cerebral edema.

Authors:  Peter Nissen Bjerring; Martin Eefsen; Bent Adel Hansen; Fin Stolze Larsen
Journal:  Metab Brain Dis       Date:  2008-12-03       Impact factor: 3.584

10.  Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro.

Authors:  Miklos Jaszberenyi; Andrew V Schally; Norman L Block; Marta Zarandi; Ren-Zhi Cai; Irving Vidaurre; Luca Szalontay; Arumugam R Jayakumar; Ferenc G Rick
Journal:  Target Oncol       Date:  2013-02-01       Impact factor: 4.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.